Lakefront Biotherapeutics NV (LKFT)

NASDAQ: LKFT · Real-Time Price · USD

28.38

+0.06 (0.21%)

At close: May 29, 2026, 4:00 PM EDT

28.35

-0.03 (-0.11%)

After-hours: May 29, 2026, 4:10 PM EDT

LKFT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,883	2,166	1,809	2,694	2,909	3,669
Market Cap Growth	7.80%	19.74%	-32.85%	-7.39%	-20.71%	-43.02%
Enterprise Value	-1,593	-1,406	-1,635	-1,503	-1,728	-1,844
Last Close Price	28.35	32.70	27.50	40.65	44.38	55.13
PE Ratio	3.34	5.75	23.59	11.51	-	-
PS Ratio	1.56	1.66	6.34	10.17	11.28	13.77
PB Ratio	0.50	0.57	0.60	0.87	1.08	1.22
P/TBV Ratio	0.50	0.57	0.66	0.94	1.17	1.24
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.01	0.01
Debt / EBITDA Ratio	0.01	0.01	-	-	-	-
Net Debt / Equity Ratio	-0.91	-0.92	-1.07	-1.31	-1.61	-1.77
Net Debt / EBITDA Ratio	-4.49	-5.26	20.26	88.61	62.18	28.64
Net Debt / FCF Ratio	9.59	11.03	9.22	8.65	7.71	8.38
Asset Turnover	0.28	0.30	0.07	0.05	0.05	0.04
Inventory Turnover	11.69	13.28	5.92	3.80	7.34	30.64
Quick Ratio	30.24	19.96	9.57	8.76	7.98	8.53
Current Ratio	30.48	20.15	9.97	9.02	8.11	8.58
Return on Equity (ROE)	16.26%	10.42%	-0.04%	-0.15%	-2.76%	-4.55%
Return on Assets (ROA)	10.66%	8.87%	-2.75%	-1.17%	-1.65%	-1.97%
Return on Invested Capital (ROIC)	241.35%	2988.46%	-	-	-	-
Return on Capital Employed (ROCE)	19.30%	16.50%	-4.90%	-2.20%	-3.10%	-3.70%
Earnings Yield	29.94%	17.39%	4.24%	8.69%	-8.01%	-3.20%
FCF Yield	-19.23%	-14.70%	-19.27%	-17.42%	-19.39%	-17.29%
Buyback Yield / Dilution	-0.03%	0.06%	-0.01%	-0.36%	-0.30%	-0.65%

SEC Filings: 10-K · 10-Q